Handling Hazardous Reactions During Intermediate Synthesis
Learn how to manage hazardous reactions during intermediate synthesis with risk assessment, process control, and safety management strategies.
Continuous Manufacturing vs. Batch Manufacturing: The Real Choice Logic in the Pharmaceutical Intermediate Stage
Compare continuous and batch manufacturing for pharmaceutical intermediates, focusing on cost, quality control, scalability, and supply chain risk.
Supply Chain Risk Management for Intermediates
Real-world insights into supply chain risk management for pharmaceutical intermediates, focusing on dual supply systems, critical raw material assurance, and compliance-driven supplier selection.
Removing Catalyst Residues in Hydrogenation Intermediates
This article explains practical approaches to controlling residual metals through catalyst selection, reaction optimization, and downstream workup design.
Solvent Selection and Recovery: Practical Experience and Reflections in Intermediate Synthesis
This article shares practical insights on solvent choice, recovery feasibility, safety, and compliance based on real manufacturing experience.
Process Safety Considerations in Intermediate Manufacturing
This article shares practical, experience-based insights into how safety risks emerge during intermediate production and how they can be effectively managed through thoughtful process design, hazard evaluation, and operational controls.
Why More Pharma Companies Outsource Intermediate Manufacturing
Why more pharma companies outsource intermediate manufacturing is no longer just a cost question. Based on real project experience, this article explains how outsourcing intermediates helps drug developers improve speed, manage impurity risk, and maintain regulatory control while focusing on core innovation.
Analytical Method Development for Intermediate Purity & Impurities
This article shares practical, field-based experience on designing robust analytical methods for complex intermediates, focusing on impurity identification, method robustness, and regulatory expectations.
The Rise of High-Potency Intermediates: Manufacturing Challenges and Control
The Rise of High-Potency Intermediates highlights a fundamental shift in pharmaceutical manufacturing, where potency-related risks emerge early at the intermediate stage. As oncology and targeted therapies expand, manufacturers must integrate exposure control, impurity strategy, and scalable process design to ensure compliance, safety, and long-term supply reliability.
Core Considerations in Designing Complex Pharmaceutical Intermediate Synthesis Routes: Practical Notes from the Field
This article shares real-world insights from two decades of pharmaceutical process development, focusing on how synthesis route design for complex intermediates directly impacts cost, scalability, impurity control, and regulatory compliance.